 |
APL STAT COMMUNICATION
March 22, 2010
To:
All APL Patients
From: APL - Algonquin Pediatrics and Arlington
Pediatrics
Re:
Rotavirus Vaccine
The physicians at APL would like to
provide you with
the latest
information regarding
the following:
Recommendation to Temporarily Suspend Usage of
GlaxoSmithKline Rotarix
(Rotavirus) Vaccine
The U.S. Food and Drug Administration (FDA) has learned that
DNA from porcine
circovirus type 1 (PCV1), a virus not known
to cause
disease in humans, is present
in the Rotarix vaccine.
Please note:
APL uses
and
has only used
the Rotateq vaccine.
The Rotateq
vaccine is still recommended and not the vaccine
in question.
To
read the full story, click
here.
If your child has received the Rotarix vaccine from another
office,
there is no need to
be alarmed. No disease has been seen
in humans from this virus.
Respectfully,
The Physicians of APL
^
Top of Page
|
